Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Aviat announced on September 11, 2024, its inability to file the Annual Report on Form 10-K for the fiscal year ending June 28, 2024, within the prescribed deadline. The management of Aviat has reported the discovery of certain material weaknesses during its preliminary assessment of internal controls over financial reporting for the aforementioned fiscal year. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
NVO | Novo Nordisk A/S | March 25, 2025 | Join |
GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
NEM | Newmont Corporation | April 01, 2025 | Join |
GSK | GSK plc | April 07, 2025 | Join |
NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
MRK | Merck & Co., Inc. | April 14, 2025 | Join |